Ethyl Acetate → 4-Fluoro-N-((6S,9S,12S)-6-formyl-9-isopropyl-8,11-dioxo-2-oxa-7,10-diaza-bicyclo[12.2.2]octadeca-1(17),14(18),15-trien-12-yl)-benzenesulfonamide

HRID 58393Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 58393
C[O:2][C:3]([C@H:5]1[NH:20][C:19](=[O:21])[C@H:18]([CH:22]([CH3:24])[CH3:23])[NH:17][C:16](=[O:25])[C@@H:15]([NH:26][S:27]([C:30]2[CH:35]=[CH:34][C:33]([F:36])=[CH:32][CH:31]=2)(=[O:29])=[O:28])[CH2:14][C:13]2=[CH:37][CH:38]=[C:10]([CH:11]=[CH:12]2)[O:9][CH2:8][CH2:7][CH2:6]1)=O.CC(C[AlH]CC(C)C)C.CCOC(C)=O>C(Cl)Cl>[F:36][C:33]1[CH:34]=[CH:35][C:30]([S:27]([NH:26][C@H:15]2[CH2:14][C:13]3=[CH:12][CH:11]=[C:10]([CH:38]=[CH:37]3)[O:9][CH2:8][CH2:7][CH2:6][C@@H:5]([CH:3]=[O:2])[NH:20][C:19](=[O:21])[C@H:18]([CH:22]([CH3:23])[CH3:24])[NH:17][C:16]2=[O:25])(=[O:28])=[O:29])=[CH:31][CH:32]=1

Komponenten

5

Reaktionsbedingungen

Temperatur
-78 °C

Versuchsvorschrift

Ester 68 (39 mg) was dissolved in DCM (6 mL) under an atmosphere of argon. The reaction was cooled to −78° C. To the resultant solution DIBAL (0.39 mL) was added dropwise. This was stirred for 2 h before being allowed to warm to rt overnight. The reaction mixture was partitioned between EtOAc and 1M hydrochloric acid. The aqueous phase was extracted again with EtOAc and the combined organic extracts were dried (MgSO4), filtered and concentrated in vacuo. Purification was achieved using flash chromatography, eluting with a gradient of 1/1 EtOAc/(50/70) petroleum ether to EtOAc to yield a light brown solid, 15 mg, 40%. Rf=0.25 (1/1 EtOAc/(50/70) petroleum ether).

Aufarbeitung

  1. temperatureto warm to rt overnight
  2. customThe reaction mixture was partitioned between EtOAc and 1M hydrochloric acid
  3. extractionThe aqueous phase was extracted again with EtOAc
  4. dry with materialthe combined organic extracts were dried (MgSO4)
  5. filtrationfiltered
  6. concentrationconcentrated in vacuo
  7. customPurification
  8. washeluting with a gradient of 1/1 EtOAc/(50/70) petroleum ether to EtOAc
  9. customto yield a light brown solid, 15 mg, 40%

Quellen und Nachweise

ORD-Eintrag
ord-94286a6b253548a0959ead3e1de72680
Quelldatensatz
uspto-grants-2016_09
Patentnummer
US09434762B2

Notizen zur Reaktion

Wird geladen…